Cardinal Health Inc
CAH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$698.00 | Vxjgps | Ykywqlwz |
Cardinal Health Earnings: Firm Wraps Up the Year With Strong Numbers and Margin Recovery
Narrow-moat Cardinal Health reported solid fourth-quarter earnings and ended the fiscal year on strong footing. Total sales of $59.9 billion were up 12% year over year, surpassing our expectations of high-single-digit growth, as a favorable prescription trend and solid performance across the board fueled the top line. After updating our model, we are raising our fair value estimate to $102 per share from $92.